“Brentuximab Vedotin effects on prognosis of refractory and relapsed peripheral T-Cell lymphoma: a systematic review” (2019) Revista de Medicina e Saúde de Brasília, 7(2). Available at: https://portalrevistas.ucb.br/index.php/rmsbr/article/view/9251 (Accessed: 23 September 2026).